Chris Wilson, Goodwin Procter LLP Partner, Co-Chair, Healthcare

Chris Wilson

PartnerCo-Chair, Healthcare
Chris Wilson
Boston
+1 617 570 3925
Chris Wilson is a partner in Goodwin’s Private Equity group. Chris serves as co-chair of the firm’s Healthcare Practice, co-chair of the firm’s Committee on Racial and Ethnic Diversity, and as a member of the firm’s Executive Committee.

Experience

Chris specializes in advising private equity sponsors and their portfolio companies in a wide variety of transactions, including leveraged buyouts, mergers and acquisitions, recapitalizations, growth equity investments, strategic transactions, joint ventures, and general corporate matters. Chris also frequently represents management teams and operating executives in sale transactions.

Chris principally focuses his practice on transactions in the healthcare services and healthcare technology verticals, and has significant experience in the consumer, business services, technology companies, financial services/asset management, and manufacturing verticals.

Chris’s recent transactional experience includes representing leading private equity and investment firms such as Goldman Sachs, InTandem Capital Partners, Ridgemont Equity Partners, Sixth Street Growth, TA Associates, Tinicum Capital Partners, and Webster Equity Partners, among others.

Credentials

Education

JD

University of Notre Dame

(cum laude)

BA

University of Miami

(with honors; valedictorian finalist)

Admissions

Bars

  • Massachusetts

Recognition & Awards

Chris is consistently recognized for his leadership and work in the private equity and healthcare sectors and has been included in a number of legal rankings. He has received accolades for his work by the following publications:

  • USA Private Equity Deal of the Year (InTandem Capital Partners acquires OrthoNebraska), Americas and Global Markets M&A Atlas Awards, 2024
  • Named “Dealmaker of the Year for Healthcare Services,” by The Deal
  • Recognized by The Minority Corporate Counsel Association (MCCA) as a 2022 Rainmaker
  • Ranked by Legal 500 2022-2024 as a Recommended Healthcare lawyer and as a recommended lawyer for Private Equity Buyouts (Middle Market) 2024
  • Named to the Boston Business Journal’s 40 Under 40 in 2020 as one of the best and brightest young achievers, innovators and leaders who have helped to make Boston a business powerhouse
  • Recognized by The National Law Journal as a Mergers & Acquisitions Trailblazer
  • Recognized by The M&A Advisor as an Emerging Leader

Publications